This area of interest involves clinical trials focused on methods to prevent or alleviate symptoms, distress, and functional burden associated with cancer or its treatment. The project supported in this scope must have the potential to improve the quality of life for cancer patients and, in some cases, may also extend their lifespan.
Topics of special interest are:
Clinical trials that are supported by rigorous and compelling preliminary pre-clinical and clinical research
Clinical trials investigating all types of treatments for symptoms, such as behavioral, integrative, pharmaceutical, and other non-pharmacological interventions
Clinical trials that test supportive care interventions that would be well-suited for broad dissemination in the community oncology environment
Correlative intervention studies to understand the biological mechanism or to understand patients at the highest risk so that therapies can be personalized, thus mitigating the symptoms caused by the main treatment being investigated
Funding Opportunities
Early Career in Supportive Care
This funding program features five annual calls for proposals from 2025 to 2029. Each year, the program aims to fund up to 2 awards, resulting in a total of up to 10 awards over the five-year period. This initiative supports innovative projects and fosters career advancements in supportive care.
We accept Letters of Intent (LOIs) all year round with cutoff deadlines for internal assessment three times per year. Once you have submitted your LOI, you will receive further information regarding timing and next steps.